Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention.
Revathi BalakrishnanJeffrey S BergerLisa TullyAnish VaniBinita ShahJoseph BurdowskiEdward FisherArthur SchwartzbardSteven SedlisHoward WeintraubJames A UnderbergAnn DanoffJames A SlaterEugenia GianosPublished in: Diabetes/metabolism research and reviews (2015)
Among patients undergoing elective percutaneous coronary intervention, a substantial number were identified with a new DM, prediabetes, and/or metabolic syndrome. Routine screening for an abnormal glucometabolic state at the time of revascularization may be useful for identifying patients who may benefit from additional targeting of modifiable risk factors.
Keyphrases
- patients undergoing
- percutaneous coronary intervention
- metabolic syndrome
- risk factors
- st segment elevation myocardial infarction
- coronary artery bypass grafting
- acute myocardial infarction
- st elevation myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- coronary artery disease
- insulin resistance
- uric acid
- type diabetes
- glycemic control
- atrial fibrillation
- cardiovascular disease
- coronary artery bypass
- clinical practice
- cardiovascular risk factors
- adipose tissue
- cancer therapy
- drug delivery
- left ventricular